Maravai Lifesciences Holdings Inc (MRVI) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Maravai Lifesciences Holdings Inc   (NASDAQ: MRVI)
 

Maravai Lifesciences Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Maravai Lifesciences Holdings Inc 's inventory turnover ratio sequentially decreased to 3.22 in the second quarter 2026, otherwise the ratio remained above the average, as MRVI's markets remain strong.Maravai Lifesciences Holdings Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 113 days, from 110 days, in the Mar 31 2026 quarter.

Within Healthcare sector 119 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1033 in the first quarter 2026, to 1126.

MRVI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Maravai Lifesciences Holdings Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MRVI Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -11.65 % -18.71 % -19.14 % -10.08 % -5.33 %
Y / Y Cost of Sales Growth -22.3 % -18.21 % -0.53 % -4.96 % 3.55 %
Inventory Turnover Ratio (TTM) 3.22 3.33 3.31 3.15 3.11
MRVI's Total Ranking # 1126 # 1033 # 968 # 1080 # 926
Average inventory processing period 113 110 110 116 117
Seq. Inventory Growth 1.9 % -0.08 % -10.66 % -2.87 % -6.24 %
Seq. Cost of Sales Growth -3.77 % -14.08 % 6.42 % -11.68 % 1.29 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 25
Healthcare Sector # 120
Overall Market # 1126

Inventory Turnover Ratio Statistics
High Average Low
3.43 3.06 2.74
(Sep 30 2023)   (Jun 30 2022)



MRVI Company Profile >> Back to MRVI Efficiency Comparisons >> Compare MRVI Inventory Turnover Ratio to its Competitors

Financial Statements
Maravai Lifesciences Holdings Inc 's Inventories $ 41 Millions Visit MRVI's Balance sheet
Maravai Lifesciences Holdings Inc 's Cost of Revenues TTM $ 135 Millions Visit MRVI's Income Statement
What are MRVI's Sales? Visit MRVI's Sales by Segment

Other Inventory Turnover Ratios
Maravai Lifesciences Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
MRVI's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for MRVI's Competitors
Inventory Turnover Ratio for MRVI's Suppliers
Inventory Turnover Ratio for MRVI's Customers

You may also want to know
MRVI's Sales Growth Rates MRVI's Pe Price to earnings ratio MRVI's Receivables Turnover Ratio MRVI's Stock Quote
MRVI's Net Income Growth Rates MRVI's Ps Price to Sales ratio MRVI's Sales per Employee MRVI's Asset Turnover Ratio
MRVI's Net Margin MRVI's Pb Price to Book ratio MRVI's Financial Strength Ratios MRVI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   7.43 $ 13.506  Millions$ 2  Millions
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions

Date modified: 2026-08-14T20:40:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.